These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
103 related items for PubMed ID: 16849575
1. Differential effect of bryostatin 1 and phorbol 12-myristate 13-acetate on HOP-92 cell proliferation is mediated by down-regulation of protein kinase Cdelta. Choi SH, Hyman T, Blumberg PM. Cancer Res; 2006 Jul 15; 66(14):7261-9. PubMed ID: 16849575 [Abstract] [Full Text] [Related]
2. Enhancement of cisplatin sensitivity of cisplatin-resistant human cervical carcinoma cells by bryostatin 1. Mohanty S, Huang J, Basu A. Clin Cancer Res; 2005 Sep 15; 11(18):6730-7. PubMed ID: 16166454 [Abstract] [Full Text] [Related]
3. Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation. Szallasi Z, Denning MF, Smith CB, Dlugosz AA, Yuspa SH, Pettit GR, Blumberg PM. Mol Pharmacol; 1994 Nov 15; 46(5):840-50. PubMed ID: 7969070 [Abstract] [Full Text] [Related]
4. Differential regulation of protein kinase C isozymes by bryostatin 1 and phorbol 12-myristate 13-acetate in NIH 3T3 fibroblasts. Szallasi Z, Smith CB, Pettit GR, Blumberg PM. J Biol Chem; 1994 Jan 21; 269(3):2118-24. PubMed ID: 8294465 [Abstract] [Full Text] [Related]
5. Divergent effects of bryostatin 1 and phorbol myristate acetate on cell cycle arrest and maturation in human myelomonocytic leukemia cells (U937). Vrana JA, Saunders AM, Chellappan SP, Grant S. Differentiation; 1998 May 21; 63(1):33-42. PubMed ID: 9615391 [Abstract] [Full Text] [Related]
6. The catalytic domain of protein kinase Cdelta confers protection from down-regulation induced by bryostatin 1. Lorenzo PS, Bögi K, Acs P, Pettit GR, Blumberg PM. J Biol Chem; 1997 Dec 26; 272(52):33338-43. PubMed ID: 9407126 [Abstract] [Full Text] [Related]
7. Bryostatin 1 inhibits phorbol ester-induced apoptosis in prostate cancer cells by differentially modulating protein kinase C (PKC) delta translocation and preventing PKCdelta-mediated release of tumor necrosis factor-alpha. von Burstin VA, Xiao L, Kazanietz MG. Mol Pharmacol; 2010 Sep 26; 78(3):325-32. PubMed ID: 20516369 [Abstract] [Full Text] [Related]
8. Synergistic action of calcium ionophore A23187 and protein kinase C activator bryostatin 1 on human B cell activation and proliferation. Drexler HG, Gignac SM, Pettit GR, Hoffbrand AV. Eur J Immunol; 1990 Jan 26; 20(1):119-27. PubMed ID: 1689659 [Abstract] [Full Text] [Related]
9. Activation of protein kinase C by phorbol 12-myristate 13-acetate suppresses the growth of lung cancer cells through KLF6 induction. Tahara E, Kadara H, Lacroix L, Lotan D, Lotan R. Cancer Biol Ther; 2009 May 26; 8(9):801-7. PubMed ID: 19333010 [Abstract] [Full Text] [Related]
10. Differential roles of the tandem C1 domains of protein kinase C delta in the biphasic down-regulation induced by bryostatin 1. Lorenzo PS, Bögi K, Hughes KM, Beheshti M, Bhattacharyya D, Garfield SH, Pettit GR, Blumberg PM. Cancer Res; 1999 Dec 15; 59(24):6137-44. PubMed ID: 10626804 [Abstract] [Full Text] [Related]
11. Phorbol 12-myristate 13-acetate inhibits FRO anaplastic human thyroid cancer cell proliferation by inducing cell cycle arrest in G1/S phase: evidence for an effect mediated by PKCdelta. Afrasiabi E, Ahlgren J, Bergelin N, Törnquist K. Mol Cell Endocrinol; 2008 Sep 24; 292(1-2):26-35. PubMed ID: 18541361 [Abstract] [Full Text] [Related]
12. Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines. Kennedy MJ, Prestigiacomo LJ, Tyler G, May WS, Davidson NE. Cancer Res; 1992 Mar 01; 52(5):1278-83. PubMed ID: 1737390 [Abstract] [Full Text] [Related]
13. Some phorbol esters might partially resemble bryostatin 1 in their actions on LNCaP prostate cancer cells and U937 leukemia cells. Kedei N, Lubart E, Lewin NE, Telek A, Lim L, Mannan P, Garfield SH, Kraft MB, Keck GE, Kolusheva S, Jelinek R, Blumberg PM. Chembiochem; 2011 May 16; 12(8):1242-51. PubMed ID: 21542090 [Abstract] [Full Text] [Related]
14. Early response gene signalling in bryostatin-stimulated primary B chronic lymphocytic leukaemia cells in vitro. Ning ZQ, Hirose T, Deed R, Newton J, Murphy JJ, Norton JD. Biochem J; 1996 Oct 01; 319 ( Pt 1)(Pt 1):59-65. PubMed ID: 8870649 [Abstract] [Full Text] [Related]
15. Involvement of protein kinase Cdelta in contact-dependent inhibition of growth in human and murine fibroblasts. Heit I, Wieser RJ, Herget T, Faust D, Borchert-Stuhlträger M, Oesch F, Dietrich C. Oncogene; 2001 Aug 23; 20(37):5143-54. PubMed ID: 11526503 [Abstract] [Full Text] [Related]
16. Inhibition of PMA-induced human T cell proliferation by bryostatin is associated with enhanced degradation of conventional protein kinase C (cPKC): Ca2+ signals restore mitogenic activity without abrogating enhanced cPKC degradation. Galron D, Tamir A, Altman A, Isakov N. Cell Immunol; 1994 Oct 01; 158(1):195-207. PubMed ID: 8087865 [Abstract] [Full Text] [Related]
17. Posttranslational regulation of Lck and a p36-38 protein by activators of protein kinase C: differential effects of the tumor promoter, PMA, and the non-tumor-promoter, bryostatin. Galron D, Ansotegui IJ, Isakov N. Cell Immunol; 1997 Jun 15; 178(2):141-51. PubMed ID: 9225005 [Abstract] [Full Text] [Related]
18. The bryostatins inhibit growth of B16/F10 melanoma cells in vitro through a protein kinase C-independent mechanism: dissociation of activities using 26-epi-bryostatin 1. Szallasi Z, Du L, Levine R, Lewin NE, Nguyen PN, Williams MD, Pettit GR, Blumberg PM. Cancer Res; 1996 May 01; 56(9):2105-11. PubMed ID: 8616857 [Abstract] [Full Text] [Related]
19. Identification of early growth response gene-1 (Egr-1) as a phorbol myristate acetate-induced gene in lung cancer cells by differential mRNA display. You L, Jakowlew SB. Am J Respir Cell Mol Biol; 1997 Nov 01; 17(5):617-24. PubMed ID: 9374113 [Abstract] [Full Text] [Related]
20. Effects of bryostatins 1 and 2 on morphological and functional differentiation of SH-SY5Y human neuroblastoma cells. Jalava AM, Heikkilä J, Akerlind G, Pettit GR, Akerman KE. Cancer Res; 1990 Jun 01; 50(11):3422-8. PubMed ID: 2334938 [Abstract] [Full Text] [Related] Page: [Next] [New Search]